BeiGene's gastric cancer drug succeeds in late-stage trial

BeiGene's gastric cancer drug succeeds in late-stage trial

Submitted by admin on April 20, 2023 - 11:41am
Source: 
Reuters
News Tags: 
BeiGene
gastric cancer
clinical trials
tislelizumab
Headline: 
BeiGene's gastric cancer drug succeeds in late-stage trial
snippet: 

 Chinese drug developer BeiGene Ltd (6160.HK) said on Thursday its experimental drug helped extend lives of patients with a type of gastric cancer in a late-stage trial.

Do Not Allow Advertisers to Use My Personal information